RhoA as a Mediator of Clinically Relevant Androgen Action in Prostate Cancer Cells

Recently, we have identified serum response factor (SRF) as a mediator of clinically relevant androgen receptor (AR) action in prostate cancer (PCa). Genes that rely on SRF for androgen responsiveness represent a small fraction of androgen-regulated genes, but distinguish benign from malignant prost...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Schmidt, Lucy J., Duncan, Kelly, Yadav, Neelu, Regan, Kevin M., Verone, Alissa R., Lohse, Christine M., Pop, Elena A., Attwood, Kristopher, Wilding, Gregory, Mohler, James L., Sebo, Thomas J., Tindall, Donald J., Heemers, Hannelore V.
Format: Artigo
Idioma:Inglês
Publicat: Endocrine Society 2012
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3355556/
https://ncbi.nlm.nih.gov/pubmed/22456196
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/me.2011-1130
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars